期刊文献+

肝纤维化诊断标准的现今认识 被引量:23

下载PDF
导出
摘要 肝纤维化是各种慢性肝病损伤修复过程的共同后果,其在肝细胞性功能障碍和门静脉性高压的发病机制中起着直接作用。同时,肝纤维化、甚至早期肝硬化具有可逆性已成为共识。因此,从临床治疗角度而言。正确评估肝纤维化的程度和进展显得十分重要,越来越多的临床医师更加关注肝纤维化的诊断,以帮助患者选择最佳的治疗时机。目前,肝纤维化诊断有赖于临床评估、血清学指标、影像学检查和组织病理学诊断等。
作者 谢青 桂红莲
出处 《诊断学理论与实践》 2009年第2期133-136,共4页 Journal of Diagnostics Concepts & Practice
  • 相关文献

参考文献20

  • 1Regev A,Berho M,Jeffers IJ,et al.Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection[J].Am J Gastroenterol,2002,97(10):2614-2618.
  • 2Standish RA,Cholongitas E,Dhillon A,et al.An appraisal of the histopathological assessment of liver fibrosis[J].Gut,2006,55(4):569-578.
  • 3Bataller R,Brenner DA.Liver fibrosis[J].J Clin Invest,2005,115(2):209-218.
  • 4Sandrin L,Fourquet B,Hasquenoph JM,et al.Transient elastography:a new noninvasive method for assessment of hepatic fibrosis[J].Ultrasound Med Biol,2003,29(12):1705-1703.
  • 5Castéra L,Vergniol J,Foucher J,et al.Prospective comparison of transient elastography,Fibrotest,APRI,and liver biopsy for the assessment of fibrosis in chronic hepatitis C[J].Gastroenterology,2005,128(2):343-350.
  • 6Ziol M,Handra-Luea A,Kettaneh A,et al.Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C[J].Hepatology,2005,41(1):48-54.
  • 7Poynard T,Aubert A,Bodossa P,et al.A simple biological index for detection of alcoholic liver disease in drinkers[J].Gastroenterology,1991,100(5 Pt 1):1397-1402.
  • 8Imbert-Bismut F,Ratziu V,Pieroni L,et al.Biochemical markers of liver fibrosis in patients with hepatitis C virus infection:a prospectivestudy[J].Lancet,2001,357(9262):1069-1075.
  • 9Myers RP,Tainturier MH,Ratziu V,et al.Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B[J].J Hepatol,2003,39(2):222-230.
  • 10桂红莲,谢青,王晖,周惠娟,蔡伟,安宝燕,姜山,许蓓,林之莓,徐玉敏.FibroTest-ActiTest对慢性乙型肝炎肝纤维化和炎症的诊断价值[J].中华肝脏病杂志,2008,16(12):897-901. 被引量:7

二级参考文献13

  • 1Rockey DC, Bissell DM. Noninvasive measures of liver fibrosis. Hepatology, 2006, 43(2 Suppl 1): S113-S120.
  • 2Imbert-Bismut F, Ratziu V, Pieroni L, et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet, 2001, 357: 1069-1075.
  • 3Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology, 2003, 38: 518-526.
  • 4Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol, 1995, 22: 696-699.
  • 5Poynard T. Diagnosis method of inflammatory, fibrotic or cancerous disease using the biochemical markers: US, 6631330B1. 2003- 07-27.
  • 6Poynard T, Imbert-Bismut F, Munteanu M, et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol, 2004, 3: 8.
  • 7Regev A, Berho M, Jeffers L J, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol, 2002, 97: 2614-2618.
  • 8Myers RP, Tainturier MH, Ratziu V, et al. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol, 2003, 39: 222-230.
  • 9Rossi E, Adams L, Prins A, et al. Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin Chem, 2003, 49: 450-454.
  • 10Poynard T, Munteanu M, Imbert-Bismut F, et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem, 2004, 50: 1344- 1355.

共引文献6

同被引文献190

引证文献23

二级引证文献106

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部